tradingkey.logo

Gilead Sciences Announces Q1 Estimated Acquired IPR&D

ReutersApr 10, 2025 8:47 PM

- Gilead Sciences Inc GILD.O:

  • GILEAD: FOR Q1, EXPECTS $253.4M IN ACQUIRED IPR&D EXPENSES

  • GILEAD: FOR Q1 , EXPECTS CHARGE OF ABOUT $0.16 TO BOTH GAAP AND NON-GAAP EPS, IN ACQUIRED IPR&D EXPENSES

Source text: [ID:]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI